Latest & greatest articles for gestational diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on gestational diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on gestational diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for gestational diabetes

101. Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus

Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus 21750276 2011 08 26 2012 05 11 2016 10 19 1935-5548 34 9 2011 Sep Diabetes care Diabetes Care Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus. 1949-51 10.2337/dc11-0269 Postpartum testing with a 75-g 2-h oral (...) glucose tolerance test or fasting plasma glucose (FPG) alone is often not performed among women with histories of gestational diabetes mellitus (GDM). Use of hemoglobin A(1c) (A1C) might increase testing. The association between A1C and glucose has not been examined in women with histories of GDM. We assessed the association of A1C ≥5.7% with FPG ≥100 mg/dL and 2-h glucose ≥140 mg/dL among 54 women with histories of GDM between 6 weeks and 36 months postpartum. A1C ≥5.7% had 65% sensitivity and 68% specificity for identifying

EvidenceUpdates2011 Full Text: Link to full Text with Trip Pro

102. Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease

Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease Screening for gestational diabetes mellitus: cost-utility of different screening strategies based on a woman's individual risk of disease Round JA, Jacklin P, Fraser RB, Hughes RG, Mugglestone MA, Holt RI Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The objective was to assess the cost-effectiveness of eight screening strategies for gestational diabetes. The authors concluded that some form of screening was usually cost-effective, but the best strategy varied

NHS Economic Evaluation Database.2011

103. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes

The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes 21414183 2011 07 13 2011 09 20 2013 11 21 1464-5491 28 8 2011 Aug Diabetic medicine : a journal of the British Diabetic Association Diabet. Med. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 972-5 10.1111/j.1464-5491.2011.03284.x To test the hypothesis that myoinositol supplementation will improve insulin sensitivity as measured (...) by markers of insulin resistance such as homeostasis model assessment of insulin resistance and adiponectin in women with gestational diabetes. The trial was carried out in diet-treated patients with gestational diabetes diagnosed in our department between April 2008 and September 2009. Subjects were randomly assigned to receive either myoinositol supplementation (4 g daily) plus folic acid (400 μg daily)-the study group-or folic acid only (400 μg daily)-the control group. Both groups received the same

EvidenceUpdates2011

104. Accuracy of the random glucose test as screening test for gestational diabetes mellitus: a systematic review

Accuracy of the random glucose test as screening test for gestational diabetes mellitus: a systematic review Accuracy of the random glucose test as screening test for gestational diabetes mellitus: a systematic review Accuracy of the random glucose test as screening test for gestational diabetes mellitus: a systematic review van Leeuwen M, Opmeer BC, Yilmaz Y, Limpens J, Serlie MJ, Mol BW CRD summary This review concluded that available evidence on the accuracy of the random glucose (...) tolerance test for gestational diabetes mellitus was limited. These conclusions should be interpreted with caution due to the possibility of missing studies. Authors' objectives To evaluate the accuracy of random glucose testing as a screening test for gestational diabetes mellitus. Searching MEDLINE and EMBASE were searched from inception to April 2008 with no language restrictions. Details of the search were reported, but exact terms were not listed. A cited reference search was conducted in Web of Science

DARE.2011

105. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study

Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study 21083860 2011 05 13 2011 11 18 2013 11 21 1471-0528 118 7 2011 Jun BJOG : an international journal of obstetrics and gynaecology BJOG Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. 880-5 10.1111/j.1471-0528.2010.02763.x To examine if oral metformin is as effective as insulin in the prevention of fetal macrosomy in pregnancies (...) complicated with gestational diabetes mellitus (GDM). Open-label prospective randomised controlled study. Maternity outpatient clinics in a secondary and tertiary level hospital in Finland. One hundred women with GDM who did not attain euglycaemia with diet. Women were randomised to therapy with insulin (n = 50) or oral metformin (n = 50). Incidence of large-for-gestational-age (LGA) infants and neonatal morbidity. There were no statistically significant differences in the incidence of LGA (8.5 versus

EvidenceUpdates2011

107. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus

Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes (...) mellitus Lohse N, Marseille E, Kahn JG Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study examined the cost-effectiveness of gestational diabetes mellitus screening and management using a mathematical model (GDModel). The authors

NHS Economic Evaluation Database.2011

108. Resistance exercise and glycemic control in women with gestational diabetes mellitus

Resistance exercise and glycemic control in women with gestational diabetes mellitus 20864072 2010 11 29 2011 01 07 2010 11 29 1097-6868 203 6 2010 Dec American journal of obstetrics and gynecology Am. J. Obstet. Gynecol. Resistance exercise and glycemic control in women with gestational diabetes mellitus. 556.e1-6 10.1016/j.ajog.2010.07.015 The objective of the study was to evaluate the effect of a resistance exercise program with an elastic band on insulin requirement and glycemic control (...) in patients with gestational diabetes mellitus (GDM). Sixty-four patients with gestational diabetes mellitus were randomly assigned into 2 groups: an exercise group (EG; n = 32) and a control group not submitted to the exercise program (CG; n = 32). A significant reduction in the number of patients who required insulin was observed in the EG (7/32) compared with the CG group (18/32) (P = .005). The percentage of time spent within the proposed target glucose range (of at least 80% of weekly measurements

EvidenceUpdates2011

109. Diagnosis and Treatment of Gestational Diabetes

Diagnosis and Treatment of Gestational Diabetes Diagnosis and Treatment of Gestational Diabetes Scientific Impact Paper No. 23 January 2011Diagnosis and Treatment of Gestational Diabetes 1. Background Historically, there has been controversy over screening and diagnosis of gestational diabetes. The 2002 National Institute for Health and Clinical Excellence (NICE) Health Technology Assessment concluded that there was insufficient evidence to advocate universal screening in pregnancy while noting (...) women. The results of this large observational study formed the basis of a reconsideration of diagnosis and screening for diabetes in a consensus report published in 2010 4 under the auspices of the International Association of Diabetes and Pregnancy Study Groups (IADPSG). A further major trial examining the effect on pregnancy outcomes of management of gestational diabetes was reported in 2009, 5 while a randomised controlled trial in 2008 examined the efficacy of metformin, 6 adding to the older

Royal College of Obstetricians and Gynaecologists2011

110. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose

Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose 20519664 2010 08 31 2010 12 16 2014 12 03 1935-5548 33 9 2010 Sep Diabetes care Diabetes Care Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. 2018-20 10.2337/dc10-0572 To determine the impact of the International Association of Diabetes (...) and Pregnancy Study Group (IADPSG) criteria on 1) gestational diabetes mellitus (GDM) diagnosis compared with the American Diabetes Association (ADA) criteria and 2) the fasting plasma glucose (FPG) to predict GDM. In 10,283 pregnant women undergoing a 75-g oral glucose tolerance test (OGTT) for universal screening of GDM, two FPG thresholds (of the OGTT) were used to rule in and to rule out GDM. The IADPSG and ADA criteria identified GDM in 3,875 (37.7%) women and 1,328 (12.9%) women, respectively (P

EvidenceUpdates2010 Full Text: Link to full Text with Trip Pro

111. Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus.

Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus. BACKGROUND: While most guidelines recommend the use of insulin in women whose pregnancies are affected by pre-existing diabetes, oral agents have obvious benefits for patient acceptability and adherence. It is necessary, however, to assess the effects of these anti-diabetic agents on maternal and infant health outcomes. Additionally, women with previous (...) gestational diabetes mellitus are increasingly found to be predisposed to impaired glucose tolerance and, despite the potential need for intervention for these women, there has been little evidence about the use of oral anti-diabetic agents by these women pre-conceptionally or during a subsequent pregnancy. OBJECTIVES: To investigate the effect of oral anti-diabetic agents in women with pre-existing diabetes mellitus, impaired glucose tolerance or previous gestational diabetes planning a pregnancy

Cochrane2010

112. Gestational diabetes mellitus (GDM). Evidence-based nutrition practice guideline.

Gestational diabetes mellitus (GDM). Evidence-based nutrition practice guideline. Gestational diabetes mellitus (GDM). Evidence-based nutrition practice guideline. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:007374 This guideline summary has been withdrawn from NGC. Please update your bookmarks. View all withdrawn summaries in the . About NGC Guideline Summaries NGC's guidelines summaries contain

American Dietetic Association2010

113. First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus

First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus 20007937 2010 03 01 2010 06 11 2016 10 19 1935-5548 33 3 2010 Mar Diabetes care Diabetes Care First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. 664-9 10.2337/dc09-1745 OBJECTIVE To determine whether maternal levels of follistatin-like-3 (FSTL3), an inhibitor of activin and myostatin involved in glucose homeostasis (...) , are altered in the first trimester of pregnancies complicated by subsequent gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS This was a nested case-control study of subjects enrolled in a prospective cohort of pregnant women with and without GDM (> or =2 abnormal values on a 100-g glucose tolerance test at approximately 28 weeks of gestation). We measured FSTL3 levels in serum collected during the first trimester of pregnancy. Logistic regression analyses were used to determine the risk

EvidenceUpdates2010 Full Text: Link to full Text with Trip Pro

114. Risk factors for gestational diabetes mellitus in Chinese women: a prospective study of 16,286 pregnant women in China

Risk factors for gestational diabetes mellitus in Chinese women: a prospective study of 16,286 pregnant women in China 19929987 2009 11 25 2010 07 29 2015 08 13 1464-5491 26 11 2009 Nov Diabetic medicine : a journal of the British Diabetic Association Diabet. Med. Risk factors for gestational diabetes mellitus in Chinese women: a prospective study of 16,286 pregnant women in China. 1099-104 10.1111/j.1464-5491.2009.02845.x To determine the incidence of gestational diabetes mellitus (GDM (...) Working Group eng Intramural NIH HHS United States Journal Article Multicenter Study Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't England Diabet Med 8500858 0742-3071 0 Blood Glucose IM Adult Asian Continental Ancestry Group Blood Glucose metabolism China epidemiology Diabetes, Gestational epidemiology etiology Female Glucose Tolerance Test Humans Incidence Mass Screening Maternal Age Obesity complications epidemiology Odds Ratio Pregnancy Prospective Studies Risk Factors 2009

EvidenceUpdates2010

115. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis

Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis Dhulkotia JS, Ola B, Fraser R, Farrell T CRD summary This review found no significant differences between oral hypoglycaemic agents and insulin in glycaemic (...) control or pregnancy outcomes in women with gestational diabetes. Patient satisfaction was higher with the oral agents because of ease of administration. The small numbers of included studies mostly with small sample sizes and of poor quality should be considered when interpreting the results Authors' objectives To compare the effects of oral hypoglycaemic agents (OHA) to insulin treatment in pregnant women with gestational diabetes Searching MEDLINE, EMBASE, National Health Service Library

DARE.2010

116. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis

Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis Horvath K, Koch K, Jeitler K, Matyas E, Bender R, Bastian H, Lange S, Siebenhofer A CRD summary This well-conducted systematic review aimed to determine the benefits and harms of specific (...) treatments for women with gestational diabetes mellitus. The authors concluded that treatment appeared to lower the risk of some perinatal or neonatal complications, but that insufficient data were available to draw conclusions on possible long-term effects of treatment. These conclusions are likely to be reliable. Authors' objectives To determine the benefits and harms of specific treatments for women with gestational diabetes mellitus. Searching MEDLINE, EMBASE, AMED, BIOSIS Previews, CCMed (Current

DARE.2010

117. What is known about options and approaches to intrapartum management of women with gestational diabetes mellitus (GDM)?

What is known about options and approaches to intrapartum management of women with gestational diabetes mellitus (GDM)?

OHRI Knowledge to Action2010

119. [Medtronic-Minimed Continuous Glucose Monitoring System for patients with type 1 diabetes mellitus and gestational diabetes: efficacy and safety]

[Medtronic-Minimed Continuous Glucose Monitoring System for patients with type 1 diabetes mellitus and gestational diabetes: efficacy and safety] Sistemes de monitoratge continu de glucosa de Medtronic-Minimed a pacients amb diabetis mellitus de tipus 1 i gestacional: eficacia i seguretat [Medtronic-Minimed Continuous Glucose Monitoring System for patients with type 1 diabetes mellitus and gestational diabetes: efficacy and safety] Sistemes de monitoratge continu de glucosa de Medtronic-Minimed (...) a pacients amb diabetis mellitus de tipus 1 i gestacional: eficacia i seguretat [Medtronic-Minimed Continuous Glucose Monitoring System for patients with type 1 diabetes mellitus and gestational diabetes: efficacy and safety] Solans M, Kotzeva A, Almazan C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Solans M, Kotzeva A, Almazan C. Sistemes de

Health Technology Assessment (HTA) Database.2010

120. Gestational diabetes: fasting capillary glucose as a screening test in a multi-ethnic, high-risk population

Gestational diabetes: fasting capillary glucose as a screening test in a multi-ethnic, high-risk population 19709144 2009 08 27 2010 04 16 2009 08 27 1464-5491 26 8 2009 Aug Diabetic medicine : a journal of the British Diabetic Association Diabet. Med. Gestational diabetes: fasting capillary glucose as a screening test in a multi-ethnic, high-risk population. 760-5 10.1111/j.1464-5491.2009.02765.x In populations at high risk of gestational diabetes mellitus (GDM), screening every pregnant woman (...) populations, would confirm the potential value of the FCG as a screening test for GDM. Agarwal M M MM Department of Pathology, Faculty of Medicine, UAE University, Al Ain, UAE. magarwal7@gmail.com Dhatt G S GS Othman Y Y Gupta R R eng Journal Article Research Support, Non-U.S. Gov't England Diabet Med 8500858 0742-3071 0 Blood Glucose IM Blood Glucose analysis Cultural Diversity Diabetes, Gestational blood diagnosis Fasting Female Glucose Tolerance Test methods Humans Mass Screening methods Predictive

EvidenceUpdates2009